Source link : https://www.newshealth.biz/health-news/crinecerfont-promising-for-congenital-adrenal-hyperplasia/
BOSTON — Crinecerfont, an investigational oral selective corticotropin-releasing factor type 1 receptor antagonist, benefits both adults and children with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, new phase 3 data suggest. In CAH, a genetic mutation causes deficiency in an enzyme, most often 21-hydroxylase, leading to impaired cortisol synthesis. This leads to increased secretion […]
Author : News Health
Publish date : 2024-06-02 16:19:30
Copyright for syndicated content belongs to the linked Source.
Categories